Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02610816Phase 3Completed
A Phase 3 trial of fluticasone propionate in eosinophilic esophagitis (EoE), sponsored by Cincinnati Children's Hospital Medical Center. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02610816.